# A Feedback Loop Between Fatty Acid Metabolism and Epigenetics in Clear Cell Renal Carcinoma

**Authors:** Zhou Ye, Qi‐Xin Hu, Ming‐Liang Wei, Ji‐Dong Chen, Jia Shi, Ning‐Rong Yang, Lu Jiang, Jian Chen, Zhi‐Yuan Chen, Wei‐Min Yu, Yu Xiao, Kai‐Yu Qian, Zilin Xu, Zhong Wang, Wen‐Lu Qi, Xin‐Yi Xiao, Yu‐Yu Duan, Yong Xiao, Lian‐Yun Li, Lin‐Gao Ju, Ming‐Kai Chen, Min Wu

PMC · DOI: 10.1002/advs.202504532 · Advanced Science · 2025-05-20

## TL;DR

This study reveals a feedback loop between fatty acid metabolism and epigenetics in clear cell renal carcinoma, highlighting FABP5 as a key player in tumor progression.

## Contribution

The study identifies FABP5 as an oncogene and uncovers a novel feedback loop between lipid metabolism and epigenetics in ccRCC.

## Key findings

- 10171 gain variant enhancer loci were identified in tumor tissues.
- FABP5 is essential for lipid droplet formation and enhancer activity in ccRCC cells.
- HIF-2α and ZNF692 regulate FABP5 expression through promoter and enhancer binding.

## Abstract

Lipid storage and epigenetic dysregulation are key features for clear cell renal carcinoma (ccRCC). However, the interplay between fatty acid metabolism and epigenetics in ccRCC remains to be further demonstrated. Here, the landscape of active enhancers is profiled in paired ccRCC samples and identifies 10171 gain variant enhancer loci (VELs) in the tumor tissues. Experimental validation reveals the enhancers targeting FABP5, FABP6, LPCAT1, MET, SEMA5B, SH3GL1, SNX33, and RHBDF2 are oncogenic. Further studies in organoids and animal models prove FABP5 as an oncogene. HIF‐2α and ZNF692 transcription factors regulate FABP5 expression through directly binding to its promoter and enhancer. FABP5 is essential for the lipid droplet formation driven by HIFs and critical for H3K27ac and enhancer activity in ccRCC cells. Thus, the study has identified potential targets for drug design and diagnosis and discovered the function of a feedback loop between epigenetics and lipid metabolism regulated by FABP5 in ccRCC.

The current study has profiled the landscape of active enhancers in ccRCC and identified FABP5 as an oncogene. FABP5 is essential for the lipid droplet formation driven by HIFs and critical for H3K27ac and enhancer activity. The study has discovered the function of a feedback loop between epigenetics and lipid metabolism regulated by FABP5 in ccRCC.

## Linked entities

- **Genes:** FABP5 (fatty acid binding protein 5) [NCBI Gene 2171], FABP6 (fatty acid binding protein 6) [NCBI Gene 2172], LPCAT1 (lysophosphatidylcholine acyltransferase 1) [NCBI Gene 79888], MET (MET proto-oncogene, receptor tyrosine kinase) [NCBI Gene 4233], SEMA5B (semaphorin 5B) [NCBI Gene 54437], SH3GL1 (SH3 domain containing GRB2 like 1, endophilin A2) [NCBI Gene 6455], SNX33 (sorting nexin 33) [NCBI Gene 257364], RHBDF2 (rhomboid 5 homolog 2) [NCBI Gene 79651], EPAS1 (endothelial PAS domain protein 1) [NCBI Gene 2034], ZNF692 (zinc finger protein 692) [NCBI Gene 55657]
- **Diseases:** clear cell renal carcinoma (MONDO:0005005), ccRCC (MONDO:0007763)

## Full-text entities

- **Genes:** SEMA5B (semaphorin 5B) [NCBI Gene 54437] {aka SEMAG, SemG}, FABP5 (fatty acid binding protein 5) [NCBI Gene 2171] {aka E-FABP, EFABP, KFABP, PA-FABP, PAFABP}, ZNF692 (zinc finger protein 692) [NCBI Gene 55657] {aka AREBP, Zfp692}, SNX33 (sorting nexin 33) [NCBI Gene 257364] {aka SH3PX3, SH3PXD3C, SNX30}, RHBDF2 (rhomboid 5 homolog 2) [NCBI Gene 79651] {aka RHBDL5, RHBDL6, TOC, TOCG, iRhom2}, SH3GL1 (SH3 domain containing GRB2 like 1, endophilin A2) [NCBI Gene 6455] {aka CNSA1, EEN, SH3D2B, SH3P8}, FABP6 (fatty acid binding protein 6) [NCBI Gene 2172] {aka I-15P, I-BABP, I-BALB, I-BAP, ILBP, ILBP3}, LPCAT1 (lysophosphatidylcholine acyltransferase 1) [NCBI Gene 79888] {aka AGPAT10, AGPAT9, AYTL2, LPCAT-1, LPLAT8, PFAAP3}, SLTM (SAFB like transcription modulator) [NCBI Gene 79811] {aka Met}
- **Diseases:** Clear Cell Renal Carcinoma (MESH:D002292), tumor (MESH:D009369)
- **Chemicals:** Fatty Acid (MESH:D005227), Lipid (MESH:D008055)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12302539/full.md

## Figures

6 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12302539/full.md

## References

34 references — full list in the complete paper: https://tomesphere.com/paper/PMC12302539/full.md

---
Source: https://tomesphere.com/paper/PMC12302539